|
N'-(4-bromophenyl)-N-(4-cyanophenyl)propanediamide |
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N'-(4-chlorophenyl)-N-(4-cyanophenyl)propanediamide |
Depiction based on curated SMILES
O
Cl
N
H
N
O
NH
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N,N'-bis(4-cyanophenyl)-2-methylpropanediamide |
Depiction based on curated SMILES
N
N
H
O
CH
3
N
NH
O
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N,N'-bis(4-cyanophenyl)propanediamide |
Depiction based on curated SMILES
O
N
NH
N
O
N
H
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N-(2,4-dimethoxyphenyl)-2-[(5-nitro-1H-benzimidazol-2-yl)thio]acetamide |
Depiction based on curated SMILES
CH
3
O
N
H
_
O
O
+
N
H
3
C
N
S
O
HN
O
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
N-(4-cyanophenyl)-N'-(4-phenoxyphenyl)propanediamide |
Depiction based on curated SMILES
O
N
N
H
O
O
NH
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N-(4-cyanophenyl)-N'-(6-cyanopyridin-3-yl)propanediamide |
Depiction based on curated SMILES
O
N
N
NH
N
O
N
H
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N-(4-cyanophenyl)-N'-[4-(trifluoromethyl)phenyl]propanediamide |
Depiction based on curated SMILES
NH
F
F
F
N
O
O
N
H
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N-phenyl-2-{[4-(thiophen-2-yl)pyrimidin-2-yl]sulfanyl}acetamide |
Depiction based on curated SMILES
NH
N
S
O
N
S
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
5beta,6alpha-Bis[4-(benzoylaminomethyl)-1H-1,2,3-triazole-1-ylmethyl]-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
O
N
H
N
HN
N
N
N
N
H
N
H
N
H
2
N
N
H
O
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem |
|
| | |